Table 2.
Laboratory findings and comorbidities of the hospitalized patients according to their vaccination status.
| All patients (N = 1888) | Unvaccinated (N = 1327) | Partially vaccinated (N = 352) | Fully vaccinated (N = 209) | Partially vaccinated p value † | Full vaccinated p value † | |
|---|---|---|---|---|---|---|
| Comorbidities | ||||||
| Any comorbidity | 705 (37·5%) | 434 (33%) | 139 (40%) | 132 (63·5%) | 0·017 | <0·0001 |
| No comorbidities | 1177 (62·5%) | 889 (67%) | 212 (60%) | 76 (36·5%) | 0·017 | <0·0001 |
| 1 Comorbidity | 447 (24%) | 306 (23%) | 84 (24%) | 57 (27%) | 0·75 | 0·18 |
| 2 Comorbidities | 157 (8%) | 83 (6%) | 38(11%) | 36 (17%) | 0·003 | <0·0001 |
| More than 2 | 101 (6%) | 45 (3%) | 17 (5%) | 39 (19%) | 0·20 | <0·0001 |
| Obesity | 330 (17·5%) | 229 (17%) | 54 (15%) | 47 (22%) | 0·399 | 0·069 |
| Hypertension | 289 (15%) | 144 (11%) | 59 (17%) | 86 (41%) | 0·002 | <0·0001 |
| Pneumophathy | 155 (8%) | 91 (7%) | 28 (8%) | 36 (17%) | 0·472 | <0·0001 |
| Diabetes mellitus | 186 (10%) | 92 (7%) | 50 (14%) | 44 (21%) | <0·0001 | <0·0001 |
| Heart disease | 78 (4%) | 37 (3%) | 14 (4%) | 27 (13%) | 0·246 | <0·0001 |
| Cancer | 39 (2%) | 23 (2%) | 6 (2%) | 10 (5%) | 0·972 | 0·009 |
| Chronic kidney disease | 31 (2%) | 13 (1%) | 5 (1%) | 13 (6%) | 0·474 | <0·0001 |
| Laboratory findings | ||||||
| Lymphocytes (units/µL) | 1190·0 (850·0–1650·0) | 1180·0 (840·0–1617·5) | 1240·0 (900·0–1725·0) | 1180·0 (850·0–1785·0) | 0·046 | 0·622 |
| Platelets (units/mL) | 237·0 (184·0–314·0) | 233·0 (180·0–313·0) | 241·0 (189·0–314·5) | 253·0 (195·25–325·25) | 0·298 | 0·038 |
| C-reactive protein (mg/L) | 34·5 (15·0–75·6) | 31·8 (14·1–68·7) | 37·05 (16·2·0–81·5) | 48·9 (21·7–102·9) | 0·017 | <0·0001 |
| Lactate dehydrog. (units/L) | 304·0 (248·0–374·0) | 313·0 (258·0–386·0) | 282·0 (232·0–352·5) | 269·0 (218·5–330·5) | <0·0001 | <0·0001 |
| Ferritin (ng/mL) | 490·0 (222·0–1028·7) | 527·0 (237·2–1083·5) | 433·0 (195·0–932·0) | 367·0 (182·0–731·0) | 0·010 | <0·0001 |
| D-dimer (ug/mL) | 400·0 (280·0–605·0) | 410·0 (280·0–600·0) | 370·0 (270·0–560·0) | 410·0 (270·0–695·0) | 0·053 | 0·659 |
| Procalcitonin (ng/mL) | 0·09 (0·05–0·17) | 0·08 (0·05–0·16) | 0·09 (0·06–0·16) | 0·11 (0·06–0·35) | 0·572 | 0·135 |
Data are the median (IQR) or the number of cases (n) and percentage (%) calculated as [n/N]*100, where N is the total number of patients in the corresponding group. †, p values were calculated by comparing the unvaccinated group and the corresponding vaccinated group (partially or fully vaccinated patients) with the χ2 test, Fisher`s exact test or Mann-Whitney U test. Lactate dehydrog., lactate dehydrogenase.